FDA DIRECT-TO-CONSUMER BROADCAST GUIDANCE TO BE EVALUATED AFTER TWO YEARS; "ADEQUATE PROVISION" OF LABELING POSSIBLE THROUGH FOUR-PART APPROACH

FDA will re-examine its direct-to-consumer broadcast policy in two years to assess the effect of its proposal to relax the brief summary requirement in TV and radio ads, the agency said in an Aug. 8 Federal Register notice.